Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Conventional lung cancer treatments were once limited to surgery, radiation, and chemotherapy. However, gefitinib, a targeted drug, was launched in 2004, and the situation changed. Cancer cases that were highly responsive to gefitinib were later discovered to have epithelial growth factor receptor (...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 electronic resource (258 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity and Pharmacokinetic Biomarkers for Personalized Non-Small Cell Lung Cancer Treatment.
by: Svedberg, Anna.
Published: (2020.) -
The treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in new era of personalised medicine / / edited by Vera Hirsh and Barbara Melosky.
by: Barbara Melosky
Published: (2015) -
Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
by: Barbara Melosky
Published: (2018) -
Targeted Cancer Therapies, from Small Molecules to Antibodies
by: Chen, Zhe-Sheng
Published: (2020) -
Small Cell Lung Cancer: A New Era Is Beginning?
by: Morabito, Alessandro
Published: (2021)